1. Bellmunt J, Orsola A, Maldonado X, Kataja V. Bladder cancer: ESMO practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2010; 21(S5):S134–S136.
Article
2. Lamm DL, van der Meijden PM, Morales A, Brosman SA, Catalona WJ, Herr HW, et al. Incidence and treatment of complications of bacillus Calmette-Guérin intravesical therapy in superficial bladder cancer. J Urol. 1992; 147:596–600. PMID:
1538436.
3. Harving SS, Asmussen L, Roosen JU, Hermann G. Granulomatous epididymo-orchitis, a rare complication of intravesical bacillus Calmette-Guérin therapy for urothelial cancer. Scand J Urol Nephrol. 2009; 43:331–333. PMID:
19396724.
Article
4. Ilgan S, Koca G, Gundogdu S. Incidental detection of granulomatous prostatitis by F-18 FDG PET/CT in a patient with bladder cancer: a rare complication of BCG instillation therapy. Clin Nucl Med. 2009; 34:613–614. PMID:
19692827.
5. Korac M, Milosevic B, Lavadinovic L, Janjic A, Brmbolic B. Disseminated BCG infection in patients with urinary bladder carcinoma. Med Pregl. 2009; 62:592–595. PMID:
20491388.
Article
6. CLSI. CLSI document MM18-A. Interpretive criteria for identification of bacteria and fungi by DNA target sequencing; approved guideline. 2008. Wayne, PA: Clinical and Laboratory Standards Institute.
7. Nakajima C, Rahim Z, Fukushima Y, Sugawara I, van der Zanden AG, Tamaru A, et al. Identification of mycobacterium tuberculosis clinical isolates in Bangladesh by a species distinguishable multiplex PCR. BMC Infect Dis. 2010; 10:118. PMID:
20470432.
Article
8. Nam SB, Park JS, Kim JJ, Park JT, Nam SK. Ureteral obstruction caused by periureteral tuberculous granuloma after intravesical BCG therapy for superficial bladder tumors. Korean J Urol. 2006; 47:436–439.
Article
9. Jeon HJ, Ham WS, Lee SH, Kim WY, Kim JH, Cho SY, et al. Renal tuberculous granuloma after intravesical bacillus Calmette-Guérin instillation for bladder tumor. Korean J Urol. 2002; 43:1104–1106.
10. Lee GS, Lee GY, Yoon JC, Na DJ, Jeong SS, Sul CK, et al. Two cases of pulmonary complications following intravesical bacillus Calmette-Guérin immunotherapy in patients with superficial bladder cancer. Tuberc Respir Dis. 1999; 46:869–878.
11. Kim SH, Kim HW, Lee HJ, Bae WJ, Cho SY. Tuberculous prostatic abscess following intravesical bacillus Calmette-Guérin instillation. Korean J Urol. 2009; 50:186–187.
Article
12. Son JI, Chung JP, Paek SS, Lee JI, Kim JH, Moon BS, et al. A case of granulomatous hepatitis developed after intravesical BCG instillation for bladder cancer. Korean J Gastroenterol. 2002; 39:375–378.
13. Kim SH, Kim SY, Eun BW, Yoo WJ, Park KU, Choi EH, et al. BCG osteomyelitis caused by the BCG Tokyo strain and confirmed by molecular method. Vaccine. 2008; 26:4379–4381. PMID:
18603342.
Article
14. Nagai S, Wiker HG, Harboe M, Kinomoto M. Isolation and partial characterization of major protein antigens in the culture fluid of mycobacterium tuberculosis. Infect Immun. 1991; 59:372–382. PMID:
1898899.
Article
15. Harboe M, Nagai S, Patarroyo ME, Torres ML, Ramirez C, Cruz N. Properties of proteins MPB64, MPB70, and MPB80 of mycobacterium bovis BCG. Infect Immun. 1986; 52:293–302. PMID:
3514457.
Article
16. Li H, Ulstrup JC, Jonassen TO, Melby K, Nagai S, Harboe M. Evidence for absence of the MPB64 gene in some substrains of mycobacterium bovis BCG. Infect Immun. 1993; 61:1730–1734. PMID:
8478061.
Article
17. Behr MA, Small PM. A historical and molecular phylogeny of BCG strains. Vaccine. 1999; 17:915–922. PMID:
10067698.
Article